Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics

Weitoft, Maria LU ; Kadefors, Måns LU ; Stenberg, Henning LU ; Tufvesson, Ellen LU ; Diamant, Zuzana LU ; Rolandsson Enes, Sara LU orcid ; Bjermer, Leif LU ; Rosmark, Oskar LU orcid and Westergren-Thorsson, Gunilla LU orcid (2022) In Respiratory Research 23(1).
Abstract

Background: A subset of individuals with allergic asthma develops a late phase response (LPR) to inhaled allergens, which is characterized by a prolonged airway obstruction, airway inflammation and airway hyperresponsiveness. The aim of this study was to identify changes in the plasma proteome and circulating hematopoietic progenitor cells associated with the LPR following inhaled allergen challenge. Methods: Serial plasma samples from asthmatics undergoing inhaled allergen challenge were analyzed by mass spectrometry and immunosorbent assays. Peripheral blood mononuclear cells were analyzed by flow cytometry. Mass spectrometry data were analyzed using a linear regression to model the relationship between airway obstruction during the... (More)

Background: A subset of individuals with allergic asthma develops a late phase response (LPR) to inhaled allergens, which is characterized by a prolonged airway obstruction, airway inflammation and airway hyperresponsiveness. The aim of this study was to identify changes in the plasma proteome and circulating hematopoietic progenitor cells associated with the LPR following inhaled allergen challenge. Methods: Serial plasma samples from asthmatics undergoing inhaled allergen challenge were analyzed by mass spectrometry and immunosorbent assays. Peripheral blood mononuclear cells were analyzed by flow cytometry. Mass spectrometry data were analyzed using a linear regression to model the relationship between airway obstruction during the LPR and plasma proteome changes. Data from immunosorbent assays were analyzed using linear mixed models. Results: Out of 396 proteins quantified in plasma, 150 showed a statistically significant change 23 h post allergen challenge. Among the most upregulated proteins were three protease inhibitors: alpha-1-antitrypsin, alpha-1-antichymotrypsin and plasma serine protease inhibitor. Altered levels of 13 proteins were associated with the LPR, including increased factor XIII A and decreased von Willebrand factor. No relationship was found between the LPR and changes in the proportions of classical, intermediate, and non-classical monocytes. Conclusions: Allergic reactions to inhaled allergens in asthmatic subjects were associated with changes in a large proportion of the measured plasma proteome, whereof protease inhibitors showed the largest changes, likely to influence the inflammatory response. Many of the proteins altered in relation to the LPR are associated with coagulation, highlighting potential mechanistic targets for future treatments of type-2 asthma.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Airway inflammation, Allergic asthma, Coagulation, Mass spectrometry, Protease inhibition
in
Respiratory Research
volume
23
issue
1
article number
50
publisher
BioMed Central (BMC)
external identifiers
  • pmid:35248034
  • scopus:85125860485
ISSN
1465-9921
DOI
10.1186/s12931-022-01968-0
language
English
LU publication?
yes
id
757b8acf-f5bc-4863-a31b-3705c0161a61
date added to LUP
2022-04-26 10:50:00
date last changed
2024-06-14 14:48:40
@article{757b8acf-f5bc-4863-a31b-3705c0161a61,
  abstract     = {{<p>Background: A subset of individuals with allergic asthma develops a late phase response (LPR) to inhaled allergens, which is characterized by a prolonged airway obstruction, airway inflammation and airway hyperresponsiveness. The aim of this study was to identify changes in the plasma proteome and circulating hematopoietic progenitor cells associated with the LPR following inhaled allergen challenge. Methods: Serial plasma samples from asthmatics undergoing inhaled allergen challenge were analyzed by mass spectrometry and immunosorbent assays. Peripheral blood mononuclear cells were analyzed by flow cytometry. Mass spectrometry data were analyzed using a linear regression to model the relationship between airway obstruction during the LPR and plasma proteome changes. Data from immunosorbent assays were analyzed using linear mixed models. Results: Out of 396 proteins quantified in plasma, 150 showed a statistically significant change 23 h post allergen challenge. Among the most upregulated proteins were three protease inhibitors: alpha-1-antitrypsin, alpha-1-antichymotrypsin and plasma serine protease inhibitor. Altered levels of 13 proteins were associated with the LPR, including increased factor XIII A and decreased von Willebrand factor. No relationship was found between the LPR and changes in the proportions of classical, intermediate, and non-classical monocytes. Conclusions: Allergic reactions to inhaled allergens in asthmatic subjects were associated with changes in a large proportion of the measured plasma proteome, whereof protease inhibitors showed the largest changes, likely to influence the inflammatory response. Many of the proteins altered in relation to the LPR are associated with coagulation, highlighting potential mechanistic targets for future treatments of type-2 asthma.</p>}},
  author       = {{Weitoft, Maria and Kadefors, Måns and Stenberg, Henning and Tufvesson, Ellen and Diamant, Zuzana and Rolandsson Enes, Sara and Bjermer, Leif and Rosmark, Oskar and Westergren-Thorsson, Gunilla}},
  issn         = {{1465-9921}},
  keywords     = {{Airway inflammation; Allergic asthma; Coagulation; Mass spectrometry; Protease inhibition}},
  language     = {{eng}},
  number       = {{1}},
  publisher    = {{BioMed Central (BMC)}},
  series       = {{Respiratory Research}},
  title        = {{Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics}},
  url          = {{http://dx.doi.org/10.1186/s12931-022-01968-0}},
  doi          = {{10.1186/s12931-022-01968-0}},
  volume       = {{23}},
  year         = {{2022}},
}